Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 10/2014

01-10-2014 | Erratum

Erratum to: Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study

Authors: Mathias Witzens-Harig, Robin Foá, Alice Di Rocco, Guy van Hazel, Dalton F. A. Chamone, Jacob M. Rowe, Luca Arcaini, Irina Poddubnaya, Anthony D. Ho, Valentina Ivanova, Andrej Vranovsky, Dan Thurley, Stephan Oertel

Published in: Annals of Hematology | Issue 10/2014

Login to get access

Excerpt

Erratum to: Ann Hematol …
Metadata
Title
Erratum to: Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study
Authors
Mathias Witzens-Harig
Robin Foá
Alice Di Rocco
Guy van Hazel
Dalton F. A. Chamone
Jacob M. Rowe
Luca Arcaini
Irina Poddubnaya
Anthony D. Ho
Valentina Ivanova
Andrej Vranovsky
Dan Thurley
Stephan Oertel
Publication date
01-10-2014
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 10/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-014-2153-6

Other articles of this Issue 10/2014

Annals of Hematology 10/2014 Go to the issue

Letter to the Editor

Pneumatosis intestinalis and imatinib mesylate

Original Article

ESHAP as salvage therapy for relapsed or refractory Hodgkin’s lymphoma

Letter to the Editor

Novel heterozygous c.798C>G and c.1040T>G mutations in the GBA1 gene are associated with a severe phenotype of Gaucher disease type 1

Letter to the Editor

Recombinant human interleukin-10 in patients with chronic myelomonocytic leukemia

Letter to the Editor

The successful management of dabigatran-associated critical end-organ bleeding with recombinant factor VIIa

Original Article

Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL)—a single region experience on consecutive patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits